NPDUIS Advisory Committee


Tanya Potashnik
Director, Policy and Economic Analysis Branch
Patented Medicine Prices Review Board


Christine Voggenreiter
Director, Economic Analysis, Pharmaceutical Services Division
British Columbia Ministry of Health

Sandra Rees 
Pharmaceutical Policy Consultant, Pharmaceuticals and Health Benefits
Alberta Health

Arlene Kuntz
Director, Professional Practice, Drug Plan and Extended Benefits Branch
Saskatchewan Ministry of Health

Patricia Caetano
Executive Director, Provincial Drug Programs
Manitoba Health

Angie Wong
Director, Drug Programs Policy and Strategy Branch, Drugs and Devices Division
Ontario Public Drug Programs

Kevin Pothier
Executive Director of Pharmaceutical Services
New Brunswick Department of Health

Kathleen Coleman
Director, Formulary and Clinical Practice
Pharmaceutical Services and Extended Health Benefits

Bonnie Corish
Pharmacist Consultant, Pharmacare Program
Health Prince Edward Island

Marguerite Mullins
Manager, Client Services and Operations, Pharmaceutical Services Division
Newfoundland and Labrador Department of Health and Community Services

Shauna Demers
Director Insured Health Services
Yukon Department of Health and Social Services

Karen Fortin
Director, Pharmacy Policy Development Division, Non-Insured Health Benefits Directorate
Indigenous Services Canada

Leoma Kwong
Senior Policy Analyst, Office of Pharmaceuticals Management Strategies
Health Canada

Brian O’Shea
Acting Manager, NPDUIS
Patented Medicine Prices Review Board

Elena Lungu
Manager, Policy Development
Patented Medicine Prices Review Board


Tracey Fisher
Manager, Pharmaceuticals
Canadian Institute for Health Information

Dr. Nicole Mittmann
Chief Scientist and VP Evidence Standards
Canadian Agency for Drugs and Technologies in Health

Tarry Ahuja
Manager, Policy & Program Development,
Canadian Agency for Drugs and Technologies in Health

Dominic Bélanger
Acting Director, Direction des affaires pharmaceutiques et du médicament
Ministère de la Santé et des Services sociaux du Québec

Daniel Sperber
Senior Economist
pan-Canadian Pharmaceutical Alliance Office

Date modified: